Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Oct 24:11:3083-3096.
doi: 10.2147/DDDT.S143712. eCollection 2017.

Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation

Rai Muhammad Sarfraz  1 , Mahmood Ahmad  2 , Asif Mahmood  3 , Muhammad Rouf Akram  1 , Asad Abrar  2
Affiliations
Comparative Study

Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation

Rai Muhammad Sarfraz et al. Drug Des Devel Ther. .

Abstract

The aim of this study was to enhance the solubility of rosuvastatin (RST) calcium by developing β-cyclodextrin-g-poly(2-acrylamido-2-methylpropane sulfonic acid [AMPS]) hydrogel microparticles through aqueous free-radical polymerization technique. Prepared hydrogel microparticles were characterized for percent entrapment efficiency, solubility studies, Fourier transform infrared spectroscopy, differential scanning calorimetry, thermal gravimetric analysis, powder X-ray diffraction, scanning electron microscopy, zeta size and potential, swelling and release studies. Formulations (HS1-HS9) have shown entrapment efficiency between 83.50%±0.30% and 88.50%±0.25%, and optimum release was offered by formulation HS7 at both pH levels, ie, 1.2 (89%) and 7.4 (92%). The majority of microparticles had a particle size of less than 500 µm and zeta potential of -37 mV. Similarly, optimum solubility, ie, 10.66-fold, was determined at pH 6.8 as compared to pure RST calcium, ie, 7.30-fold. In vivo studies on fabricated hydrogel microparticulate system in comparison to pure drug were carried out, and better results regarding pharmacokinetic parameters were seen in the case of hydrogel microparticles. A potential approach for solubility enhancement of RST calcium and other hydrophobic moieties was successfully developed.

Keywords: hydrogel microparticles; polymerization; rosuvastatin calcium; β-cyclodextrin solubility.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Schematic representation of hydrogel microparticle synthesis. Abbreviations: AMPS, 2-acrylamido-2-methylpropane sulfonic acid; APS, ammonium persulfate; β-CD, β-cyclodextrin; MBA, N,N′-methylene bisacrylamide.
Figure 2
Figure 2
FTIR spectra of (A) RST calcium, (B) β-cyclodextrin, (C) MBA, (D) AMPS, (E) APS, (F) physical mixture of β-CD and RST calcium, (G) physical mixture of RST, APS, AMPS and MBA, (H) hydrogel microparticles. Abbreviations: AMPS, 2-acrylamido-2-methylpropane sulfonic acid; APS, ammonium persulfate; β-CD, β-cyclodextrin; FTIR, Fourier transform infrared; MBA, N,N′-methylene bisacrylamide; RST, rosuvastatin.
Figure 3
Figure 3
DSC (left) and TGA (right) curves of (A) RST calcium, (B) β-CD, (C) hydrogel microparticles. Abbreviations: β-CD, β-cyclodextrin; DSC, differential scanning calorimetry; RST, rosuvastatin; TGA, thermal gravimetric analysis.
Figure 4
Figure 4
Scanning electron micrographs of lyophilized hydrogel microparticles.
Figure 5
Figure 5
PXRD pattern of (A) RST calcium, (B) β-CD, (C) physical mixture and (D) hydrogel microparticles. Abbreviations: β-CD, β-cyclodextrin; PXRD, powder X-ray diffraction; RST, rosuvastatin.
Figure 6
Figure 6
TEM micrograph of lyophilized hydrogel microparticles. Abbreviation: TEM, transmission electron microscopy.
Figure 7
Figure 7
Zeta size and zeta potential. Notes: (A) Zeta size measurement of hydrogel microparticles. (B) Zeta potential measurements of hydrogel microparticles.
Figure 8
Figure 8
In vitro drug release profiles. Notes: (A) Cumulative% drug release from hydrogel microparticles and RST tablets at pH 6.8. (B) Cumulative% drug release from hydrogel microparticles and RST tablets at pH 1.2. Abbreviation: RST, rosuvastatin.
Figure 9
Figure 9
Solubility studies of pure drug and hydrogel microparticles. Abbreviations: AMPS, 2-acrylamido-2-methylpropane sulfonic acid; β-CD, β-cyclodextrin; RST, rosuvastatin.
Figure 10
Figure 10
ES% at pH 1.2 and pH 7.4 (HS7). Abbreviation: ES%, equilibrium swelling percent.
Figure 11
Figure 11
Combined plasma profile of RST calcium after the administration of hydrogel microparticles and commercially available RST tablets. Abbreviation: RST, rosuvastatin.
See this image and copyright information in PMC

References

    1. Perrut M, Jung J, Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes: part I: micronization of neat particles. Int J Pharm. 2005;288(1):3–10. - PubMed
    1. Ku MS, Dulin W. A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical proof of concept. Pharm Dev Technol. 2012;17(3):285–305. - PubMed
    1. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23:3–25. - PubMed
    1. Hiroaki KUBO, Osawa T, Takashima K, Mizobe K. Enhancement of oral bioavailability and pharmacological effect of 1-(3, 4-dimethoxyphenyl)-2, 3-bis (methoxycarbonyl)-4-hydroxy-6, 7, 8-trimethoxynaphthalene (TA-7552), a new hypocholesterolemic agent, by micronization in co-ground mixture with D-mannitol. Biol Pharm Bull. 1996;19:741–747. - PubMed
    1. Martis L, Hall NA, Thakkar AL. Micelle formation and testosterone solubilization by sodium glycocholate. J Pharm Sci. 1972;61(11):1757–1761. - PubMed

Publication types

MeSH terms